Receptor-mediated Delivery of SiRNAs by Tethered Nucleic Acid Base-paired Interactions
Overview
Affiliations
We report a new strategy for cell-type-specific delivery of functional siRNAs into cells. The method involves the noncovalent attachment of siRNAs to ligand-conjugated oligodeoxynucleotides via nucleic acid base-paired interactions. The resulting complexes can be directly applied to cells, leading to specific cellular uptake and gene silencing. The method is simple, economical, and can be easily adapted for other cell surface receptors. Here we show the application of this method for the delivery of siRNAs to folate receptor-expressing cells.
Auchynnikava T, Aarela A, Moisio O, Liljenback H, Andriana P, Iqbal I ACS Omega. 2025; 10(6):6003-6014.
PMID: 39989783 PMC: 11840764. DOI: 10.1021/acsomega.4c10047.
Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases.
Abdelaal A, Kasinski A NAR Cancer. 2021; 3(3):zcab030.
PMID: 34316717 PMC: 8291076. DOI: 10.1093/narcan/zcab030.
FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.
Orellana E, Tenneti S, Rangasamy L, Lyle L, Low P, Kasinski A Sci Transl Med. 2017; 9(401).
PMID: 28768807 PMC: 5576188. DOI: 10.1126/scitranslmed.aam9327.
New type of BACE1 siRNA delivery to cells.
Jablkowski M, Szemraj M, Oszajca K, Janiszewska G, Bartkowiak J, Szemraj J Med Sci Monit. 2014; 20:2598-606.
PMID: 25491230 PMC: 4266366. DOI: 10.12659/MSM.891219.
Site-specific antibody-polymer conjugates for siRNA delivery.
Lu H, Wang D, Kazane S, Javahishvili T, Tian F, Song F J Am Chem Soc. 2013; 135(37):13885-91.
PMID: 23924037 PMC: 3955097. DOI: 10.1021/ja4059525.